Neurogene Inc. (NGNE) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Mar 24, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Neurogene Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Neurogene Inc.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Neurogene Inc. actually do?
Answer:
Neurogene Inc. is a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases, aiming to transform complex, devastating conditions into treatable ones. The company's proprietary EXACTTM transgene regulation technology utilizes microRNA-based genetic circuits to precisely control transgene expression, addressing limitations of conventional gene therapy. Its lead program, NGN-401, is in Phase 3 development for Rett syndrome, utilizing AAV delivery via an intracerebroventricular infusion. Neurogene operates a fully operational cGMP manufacturing facility in Houston, Texas, providing control over product quality and development timelines. The company has a limited operating history, has not yet generated product revenue, and expects to incur significant losses as it advances its pipeline.
Question:
What are Neurogene Inc.'s revenue drivers?
Answer:
The company has not generated any product sales revenue. Revenue in prior periods was derived from licensing agreements related to the disposition of legacy assets from a prior business combination.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required